Skip to main content
SpringerLink
Log in

The sick building syndrome as a part of the autoimmune (auto-inflammatory) syndrome induced by adjuvants

Modern Rheumatology

Cite this article

Abstract

Sick building syndrome (SBS) is a term coined for a set of clinically recognizable symptoms and ailments without a clear cause reported by occupants of a building. In the 1990s the term “functional somatic syndromes” was applied to several syndromes, including SBS, multiple chemical sensitivity, repetition stress injury, the side effects of silicone breast implants, the Gulf War syndrome (GWS), chronic fatigue syndrome, the irritable bowel syndrome, and fibromyalgia. Recently, Shoenfeld and Agmon-Levin suggested that four conditions—siliconosis, macrophagic myofascitis, the GWS, and post-vaccination phenomena—which share clinical and pathogenic resemblances, may be included under a common syndrome entitled the “autoimmune (auto-inflammatory) syndrome induced by adjuvants”. Comparison of the clinical manifestations, symptoms, and signs of the four conditions described by Shoenfeld and Agmon-Levin with those described for SBS shows that nine out of ten main symptoms are present in all 5 conditions. Shoenfeld and Agmon-Levin further propose several major and minor criteria, which, although requiring further validation, may aid in the diagnosis of this newly defined syndrome. We propose here that SBS may also be included as a part of “Shoenfeld’s syndrome”.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fanger PO. Hidden olfs in sick buildings. ASHRAE. 1988;30:40–3.

    Google Scholar 

  2. WHO. Indoor air quality research. EURO Rep Stud. 1986;103:1–64.

  3. Norback D. An update on sick building syndrome. Curr Opin Allergy Clin Immunol. 2009;9:55–9.

    Article  PubMed  Google Scholar 

  4. Finnegan MJ, Pickering CA, Burge PS. The sick building syndrome: prevalence studies. Br Med J (Clin Res Ed). 1984;289:1573–5.

    Article  CAS  Google Scholar 

  5. Brasche S, Bullinger M, Morfeld M, Gebhardt HJ, Bischof W. Why do women suffer from sick building syndrome more often than men? Subjective higher sensitivity versus objective causes. Indoor Air. 2001;11:217–22.

    Article  PubMed  CAS  Google Scholar 

  6. Stenberg B, Wall S. Why do women report ‘sick building symptoms’ more often than men? Soc Sci Med. 1995;40:491–502.

    Article  PubMed  CAS  Google Scholar 

  7. Burge S, Hedge A, Wilson S, Bass JH, Robertson A. Sick building syndrome: a study of 4373 office workers. Ann Occup Hyg. 1987;31:493–504.

    Article  PubMed  CAS  Google Scholar 

  8. Bardana EJ Jr, Montanaro A, O’Hollaren MT. Building-related illness. A review of available scientific data. Clin Rev Allergy. 1988;6:61–89.

    PubMed  Google Scholar 

  9. Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y. Adjuvants and autoimmunity. Lupus. 2009;18:1217–25.

    Article  PubMed  CAS  Google Scholar 

  10. Nancy AL, Shoenfeld Y. Chronic fatigue syndrome with autoantibodies—the result of an augmented adjuvant effect of hepatitis-B vaccine and silicone implant. Autoimmun Rev. 2008;8:52–5.

    Article  PubMed  Google Scholar 

  11. Shoenfeld Y, Agmon-Levin N. “ASIA”—autoimmune (auto-inflammatory) syndrome induced by adjuvant. J Autoimmun. 2010; [Epub ahead of print].

  12. Chang CC, Ruhl RA, Halpern GM, Gershwin ME. Building components contributors of the sick building syndrome. J Asthma. 1994;31:127–37.

    Article  PubMed  CAS  Google Scholar 

  13. Ruhl RA, Chang CC, Halpern GM, Gershwin ME. The sick building syndrome. II. Assessment and regulation of indoor air quality. J Asthma. 1993;30:297–308.

    Article  PubMed  CAS  Google Scholar 

  14. Assoulin-Daya Y, Leong A, Shoenfeld Y, Gershwin ME. Studies of sick building syndrome. IV. Mycotoxicosis. J Asthma. 2002;39:191–201.

    Article  PubMed  Google Scholar 

  15. Schutze N, Lehmann I, Bonisch U, Simon JC, Polte T. Exposure to mycotoxins increases the allergic immune response in a murine asthma model. Am J Respir Crit Care Med. 2010;181:1188–99.

    Article  PubMed  Google Scholar 

  16. Straus DC. Molds, mycotoxins, and sick building syndrome. Toxicol Ind Health. 2009;25:617–35.

    Article  PubMed  CAS  Google Scholar 

  17. Meggs WJ. RADS and RUDS—the toxic induction of asthma and rhinitis. J Toxicol Clin Toxicol. 1994;32:487–501.

    Article  PubMed  CAS  Google Scholar 

  18. Steerenberg PA, Withagen CE, Dormans JA, van Dalen WJ, van Loveren H, Casee FR. Adjuvant activity of various diesel exhaust and ambient particles in two allergic models. J Toxicol Environ Health A. 2003;66:1421–39.

    Article  PubMed  CAS  Google Scholar 

  19. Diaz-Sanchez D, Tsien A, Fleming J, Saxon A. Combined diesel exhaust particulate and ragweed allergen challenge markedly enhances human in vivo nasal ragweed-specific IgE and skews cytokine production to a T helper cell 2-type pattern. J Immunol. 1997;158:2406–13.

    PubMed  CAS  Google Scholar 

  20. Li N, Wang M, Bramble LA, Schmitz DA, Schauer JJ, Sioutas C, et al. The adjuvant effect of ambient particulate matter is closely reflected by the particulate oxidant potential. Environ Health Perspect. 2009;117:1116–23.

    PubMed  CAS  Google Scholar 

  21. Schober W, Lubitz S, Belloni B, Gebauer G, Lintelmann J, Matuschek G, et al. Environmental polycyclic aromatic hydrocarbons (PAHs) enhance allergic inflammation by acting on human basophils. Inhal Toxicol. 2007;19(Suppl 1):151–6.

    Article  PubMed  CAS  Google Scholar 

  22. Barsky AJ, Borus JF. Functional somatic syndromes. Ann Intern Med. 1999;130:910–21.

    PubMed  CAS  Google Scholar 

  23. Kipen HM, Fiedler N. Environmental factors in medically unexplained symptoms and related syndromes: the evidence and the challenge. Environ Health Perspect. 2002;110(Suppl 4):597–9.

    PubMed  Google Scholar 

  24. Binder LM, Campbell KA. Medically unexplained symptoms and neuropsychological assessment. J Clin Exp Neuropsychol. 2004;26:369–92.

    Article  PubMed  Google Scholar 

  25. Chang C, Gershwin ME. Indoor air quality and human health: truth vs mass hysteria. Clin Rev Allergy Immunol. 2004;27:219–39.

    Article  PubMed  Google Scholar 

  26. Chang CC, Ruhl RA, Halpern GM, Gershwin ME. The sick building syndrome. I. Definition and epidemiological considerations. J Asthma. 1993;30:285–95.

    Article  PubMed  CAS  Google Scholar 

  27. Mahmoudi M, Gershwin ME. Sick building syndrome. III. Stachybotrys chartarum. J Asthma. 2000;37:191–8.

    Article  PubMed  CAS  Google Scholar 

  28. Tsai YJ, Gershwin ME. The sick building syndrome: what is it when it is? Compr Ther. 2002;28:140–4.

    Article  PubMed  Google Scholar 

  29. Garabrant DH, Dumas C. Epidemiology of organic solvents and connective tissue disease. Arthritis Res. 2000;2:5–15.

    Article  PubMed  CAS  Google Scholar 

  30. Molina V, Shoenfeld Y. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity. 2005;38:235–45.

    Article  PubMed  CAS  Google Scholar 

  31. Kanazawa A, Kishi R. Potential risk of indoor semivolatile organic compounds indoors to human health. Nippon Eiseigaku Zasshi. 2009;64:672–82.

    Article  PubMed  CAS  Google Scholar 

  32. Koren HS, Graham DE, Devlin RB. Exposure of humans to a volatile organic mixture. III. Inflammatory response. Arch Environ Health. 1992;47:39–44.

    Article  PubMed  CAS  Google Scholar 

  33. Agmon-Levin N, Paz Z, Israeli E, Shoenfeld Y. Vaccines and autoimmunity. Nat Rev Rheumatol. 2009;5:648–52.

    Article  PubMed  Google Scholar 

  34. Bar-Meir E, Eherenfeld M, Shoenfeld Y. Silicone gel breast implants and connective tissue disease—a comprehensive review. Autoimmunity. 2003;36:193–7.

    Article  PubMed  Google Scholar 

  35. Zandman-Goddard G, Blank M, Ehrenfeld M, Gilburd B, Peter J, Shoenfeld Y. A comparison of autoantibody production in asymptomatic and symptomatic women with silicone breast implants. J Rheumatol. 1999;26:73–7.

    PubMed  CAS  Google Scholar 

  36. Campbell AW, Thrasher JD, Madison RA, Vojdani A, Gray MR, Johnson A. Neural autoantibodies and neurophysiologic abnormalities in patients exposed to molds in water-damaged buildings. Arch Environ Health. 2003;58:464–74.

    Article  PubMed  CAS  Google Scholar 

  37. Cooley JD, Wong WC, Jumper CA, Hutson JC, Williams HJ, Schwab CJ, et al. An animal model for allergic penicilliosis induced by the intranasal instillation of viable Penicillium chrysogenum conidia. Thorax. 2000;55:489–96.

    Article  PubMed  CAS  Google Scholar 

  38. Gray MR, Thrasher JD, Crago R, Madison RA, Arnold L, Campbell AW, et al. Mixed mold mycotoxicosis: immunological changes in humans following exposure in water-damaged buildings. Arch Environ Health. 2003;58:410–20.

    PubMed  Google Scholar 

  39. Lander F, Meyer HW, Norn S. Serum IgE specific to indoor moulds, measured by basophil histamine release, is associated with building-related symptoms in damp buildings. Inflamm Res. 2001;50:227–31.

    Article  PubMed  CAS  Google Scholar 

  40. Meggs WJ. Neurogenic switching: a hypothesis for a mechanism for shifting the site of inflammation in allergy and chemical sensitivity. Environ Health Perspect. 1995;103:54–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. The Chaim Zabludowicz Center for Autoimmune Diseases, Chaim Sheba Medical Center, 52621, Tel-Hashomer, Israel

    Eitan Israeli

  2. Tel-Aviv University and the Institute for Occupational Safety and Hygiene, Tel Aviv, Israel

    Asher Pardo

Authors
  1. Eitan Israeli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Asher Pardo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eitan Israeli.

About this article

Cite this article

Israeli, E., Pardo, A. The sick building syndrome as a part of the autoimmune (auto-inflammatory) syndrome induced by adjuvants. Mod Rheumatol 21, 235–239 (2011). https://doi.org/10.1007/s10165-010-0380-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10165-010-0380-9

Keywords

search

Navigation